YY, Y., RR, D., & DX, X. (2024). Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway. Drug design, development and therapy, 18, 1499. https://doi.org/10.2147/DDDT.S443479
Chicago Style (17th ed.) CitationYY, Yang, Deng RR, and Xiang DX. "Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway." Drug Design, Development and Therapy 18 (2024): 1499. https://doi.org/10.2147/DDDT.S443479.
MLA (9th ed.) CitationYY, Yang, et al. "Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway." Drug Design, Development and Therapy, vol. 18, 2024, p. 1499, https://doi.org/10.2147/DDDT.S443479.